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Original Article
Family-based association analysis to finemap
bipolar linkage peak on chromosome 8q24
using 2,500 genotyped SNPs and 15,000
imputed SNPs
Bipolar disorder (BP) is a common, complex
psychiatric disease characterized by recurrent
depression and manias, with an estimated lifetime
prevalence of about 1% (1). Family and twin
studies have reported a strong familial aggregation
of BP, suggesting that genetic factors account for
60–85% of disease risk (2). While a large number of
genetic variants were reported to be either linked or
associated with BP, few have been replicated (3, 4).
Large, genome-wide association studies (GWAS)
were able to identify the first BP genes. Ferreira
et al. (5) analyzed a combined sample of 4,387 BP
patients and 6,209 controls and reported genome-
wide significant associations to BP with single
nucleotide polymorphisms (SNPs) in Ankyrin 3
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Objective: Multiple linkage and association studies have suggested
chromosome 8q24 as a promising candidate region for bipolar disorder
(BP). We performed a detailed association analysis assessing the
contribution of common genetic variation in this region to the risk of BP.
Methods: We analyzed 2,756 single nucleotide polymorphism (SNP)
markers in the chromosome 8q24 region of 3,512 individuals from 737
families. In addition, we extended genotype imputation methods to
family-based data and imputed 22,725 HapMap SNPs in the same region
on 8q24. We applied a family-based method to test 15,552 high-quality
genotyped or imputed SNPs for association with BP.
Results: Our association analysis identified the most significant marker
(p = 4.80 · 10)5), near the gene encoding potassium voltage-gated
channel KQT-like protein (KCNQ3). Other marginally significant
markers were located near adenylate cyclase 8 (ADCY8) and ST3
beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1).
Conclusions: We developed an approach to apply MACH imputation
to family-based data, which can increase the power to detect association
signals. Our association results showed suggestive evidence of
association of BP with loci near KCNQ3, ADCY8, and ST3GAL1.
Consistent with genes identified by genome-wide association studies for
BP, our results suggest the involvement of ion channelopathy in BP
pathogenesis. However, common variants are insufficient to explain
linkage findings in 8q24; other genetic variation should be explored.
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(ANK3) and in the alpha 1C subunit of the L-type
voltage-gated calcium channel (CACNA1C), and
the same SNPs in both ANK3 (6) and CACNA1C
(7) were replicated by independent studies. How-
ever, these two variants account only for a small
proportion of BPs heritability; most heritable risk
remains unexplained.
Some of this heritability may be explained by
variants located in regions previously identified by
linkage studies (4). Since the development and
subsequent evolution of the human genome map
and modern mapping methodologies, over 40
genome-wide linkage reports on BP and at least
three meta-analyses (8, 9) were published [for a
review see Barnett and Smoller (10)]. We first
reported linkage to BP on the 8q24 region with a
nonparametric linkage (NPL) score of 3.25 (11,
12). Cichon et al. (13) also reported a genome-wide
significant two-point logarithm of odds (LOD)
score (D8S514; LOD = 3.62) at 8q24 in a genome-
wide linkage scan of 75 BP families. These results
were included in a meta-analysis of 11 studies by
McQueen et al. (9) which reported a genome-wide
significant LOD score of 3.40 in a region on
chromosome 8q24 under a broad model of BP
[bipolar I disorder (BP-I) and bipolar II disorder
(BP-II)]. Moreover, Macayran et al. (14) reported
a child with BP carrying a duplication of 8q22.1-
q24.1 caused by an unbalanced translocation.
To identify the genetic variants that account for
the linkage signal in this region, we previously
performed an association analysis with 249 candi-
date gene SNPs covering a 3.4 Mb region in a
sample of 583 affected offspring from 258 nuclear
families with evidence of linkage to BP. We
detected a suggestive level of associations with
SNPs three kb upstream of ST3GAL1 (15). We
further typed an extended sample of 3,512 individ-
uals from 737 multiplex families for 1,458 SNPs
across a 16 Mb region on 8q24. We tested each
marker for association with BP and found sugges-
tive but not experiment-wide significant associa-
tions with SNPs in several genes (16).
However, this SNP panel tagged (r2 > 0.8) only
54% of known common polymorphisms in the
8q24 region (16). To fill the gaps, we designed a
complementary panel of 1,536 additional SNPs in
the same 8q24 region and typed the panel on the
same sample (16). Here we present the joint
analysis of all 3,072 SNPs. Furthermore, we
developed an approach to apply the imputation
method MACH (17) to family-based data. We
imputed 22,725 HapMap SNPs in a 18 Mb
region on 8q24 flanking the linkage peak reported
by McQueen et al. (9). After careful data cleaning,
we tested all remaining variants for association
with BP, and obtained evidence of a suggestive
level of association between BP with loci near
KCNQ3, ADCY8, and ST3GAL1. None of the
observed associations is sufficient to account for
the previously reported linkage signal.
Materials and methods
Samples
This study combined the Johns Hopkins sample of
65 families and the National Institute of Mental
Health (NIMH) sample of 672 families; both sam-
ples have been described elsewhere [Hopkins sample
(11); NIMH sample (11, 18; see also https://www.
nimhgenetics.org/nimh_human_genetics_initiative/)].
Both samples collected multiplex families segregat-
ingBP, ascertained for a linkage study ofBP.Family
members were assessed using the Schedule for
Affective Disorders–Lifetime Version (SADS-L)
(19) or the Diagnostic Interview for Genetic Studies
(DIGS) (20). Diagnoses of BP-I and schizoaffective
disorder, bipolar type (SABP) were based on
Research Diagnostic Criteria (RDC) in the first
sample andDSM-III-R criteria in the second sample
(criteria are essentially the same). BP-II diagnosis
was based onRDC, with the additional requirement
of recurrent major depression. The final best-
estimate diagnostic procedure engaged two nonin-
terviewing psychiatrists to review all the data for a
consensus clinical diagnosis. In the case of disagree-
ment, a third psychiatrist reviewed discordant
diagnoses and adjudicated a final diagnosis.
Our sample comprised 3,525 genotyped individ-
uals, including 1,391 males and 2,134 females from
737 families (16). As the initial linkage peak was
obtained using a broad definition of affected ⁄
unaffected status, we defined individuals diagnosed
with BP-I, schizoaffective disorder, SABP, or BP-II
as affected (n = 1,958), and individuals who were
determined to have never been diagnosed with BP,
depression, schizophrenia, or any Axis I diagnosis
as unaffected (n = 515). The remaining individuals
were defined as phenotype uncertain (n = 1,052);
in this category were individuals with borderline or
uncertain affective disorders such as single episodes
of depression and nonaffective disorders such as
substance use disorders, anxiety disorders, and
other illness that could have potentially been an
expression of overlapping vulnerability with mood
disorders.
Genotype data
Genotype data were collected in two phases.
We selected 1,536 SNPs in the region from
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123.1–139.1 Mb (Build 35) on chromosome 8q24
using FESTA (21) for the first phase that was
performed at the Center of Inherited Disease
Research (CIDR) (16). We aimed to tag all the
known common variants [minor allele frequency
(MAF) > 0.05] with r2 ‡ 0.5 in region 123–131 Mb
identified byCichon et al. (13) and r2 ‡ 0.8 in region
131–139 Mb identified by McInnis et al. (11). After
careful quality control (16), 1,461 SNPs were
included in the final analysis.
To improve coverage, we selected and typed
additional 1,536 SNPs conditional on the first
marker set using FESTA (21). We designed this
marker set to maximize the number of SNPs
tagged using the same r2 and MAF criteria as in
phase I. Moreover, we retyped 24 SNPs from phase
I to estimate genotyping error rates. All markers
were selected to have an Illumina (Illumina, Inc.,
San Diego, CA, USA) design cutoff score of 0.6,
per manufacturers instructions, to generate a
customized Illumina panel of 1,536 SNPs. These
SNPs were genotyped using the University of
Michigans Department of Psychiatry ⁄Molecular
and Behavioral Neuroscience Institute (Ann
Arbor, MI, USA) microarray core facility on a
local Illumina BeadStation system, following man-
ufacturers instructions.
Quality control of the phase II data used
PEDSTATS (22). We removed all SNPs that did
not satisfy all of the following criteria: successful
genotyping rate ‡ 90%; number of non-Mendelian
inheritance (NMI) errors < 6; Hardy–Weinberg
equilibrium (HWE) test using the entire sample
with p-value ‡ 10)6; and MAF ‡ 5%. After apply-
ing these quality-control criteria, we retained 1,295
SNPs of the 1,536 for analysis for a combined
dataset of 2,756 SNPs.
Statistical analyses
Single-marker association analysis. We performed
single-marker association tests with the program
LAMP (23), a maximum-likelihood method that
jointly models linkage and association, to incor-
porate the large family sizes in our dataset (max-
imum family size: n = 23). For our main analysis,
we assumed a multiplicative model with a popula-
tion prevalence of 1%. In addition, we compared
to the results obtained under dominant ⁄ recessive
and a free model without any genetic model
assumptions.
Imputation. We used the program MACH (17) to
impute genotypes for all markers in the 8q24
region using the CEU population from HapMap
(Build 35) database as references (24). MACH
implements a hidden Markov model to impute
unknown SNP genotypes, modeling samples as
unrelated individuals. To extend the algorithm to
related individuals, we performed MACH in two
steps. First, we selected 200 independent individ-
uals from our sample and analyzed them with
MACH to calibrate imputation parameters such as
the estimates of imputation error rates. Based on
these estimates, we then imputed genotypes for the
entire sample, treating individuals as independent.
In total, we imputed 22,725 SNPs in an 18 Mb
region by expanding one Mb at each end of our
genotyped region.
We estimated imputation error rates by masking
2% of the original genotypes before imputation
and then comparing the true genotypes with their
imputed counterparts. To identify and remove
poorly imputed markers, we evaluated three sta-
tistics: First, we removed all markers with
MAF < 0.05 (n = 1,905). Second, we assessed
the estimated squared correlation between imputed
genotypes and true genotypes r̂2 calculated by
MACH. We excluded markers with r̂2<0.3
(n = 4,225), which has been shown to remove
70% of badly imputed SNPs (17). Moreover, the
family structure in our dataset allowed us to
estimate the imputation quality by counting the
number of NMIs for each imputed SNP. We
removed imputed SNPs with >30 NMIs
(n = 1,042). A total of 15,552 SNPs were included
in the final association analysis.
Results
Genotyping quality and coverage
We estimated the genotyping error rate by com-
paring genotypes of 24 SNPs that were typed in
both phases for all individuals. The estimated
average mismatch rate was 0.26% per SNP. The
combined marker set tagged 94.1% (78.3%) of
the common HapMap SNPs (MAF > 0.05) in the
8q24 region with r2 ‡ 0.50 (r2 ‡ 0.80).
Single-marker association analysis
We tested each SNP for association with BP
conditional on the underlying family structure
using LAMP (23), assuming a multiplicative model
with a disease prevalence of 1%. The most signif-
icantly associated marker was rs2673582
(p = 4.80 · 10)5), which is located 27 Kb
upstream of KCNQ3 (Fig. 1). Applying Bonferroni
correction for an experiment-wide type 1 error
probability of 0.05 with 2,756 tests generates a
single-marker critical value of 1.8 · 10)5. Hence,
Zhang et al.
788
the observed p-value can be considered to be
suggestively significant. Three other SNPs had
p-values < 10)3, two of which (rs3750889 and
rs1023096) are located within ADCY8 gene and are
in high linkage disequilibrium (r2 = 0.86)
(Table 1). A marker identified by Zandi et al.
(16) in ST3GAL1 was ranked fifth in our analysis
(p = 1.1 · 10)3). Results obtained under a dom-
inant ⁄ recessive model or a free model were not
fundamentally different (data not shown).
Imputation
To assess the performance of the imputation
method MACH on family-based data, we ran-
domly masked 2% of genotypes and treated them
as missing, then estimated the performance by
comparing the imputed genotypes to the true
genotypes. The estimated imputation error rate
was 0.0577 per genotype and 0.035 per allele,
respectively. We further assessed the quality of
Fig. 1. The top panel shows p-values ()log10p) from an association test for each genotyped SNP versus position (Mb) across linkage
peak on 8q24 (9). The bottom panel magnifies one Mb surrounding the most significant marker rs2673582 (purple diamond). Below
each plot, a subset of genes in this region is shown. Light gray lines display recombination rates as estimated from HapMap. The
colors of the circles indicate the strength of linkage disequilibrium (LD) with rs2673582; gray circles indicate missing LD information
(36). The horizontal line indicates an experiment-wide significance threshold according to Bonferroni correction for multiple tests.
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imputed genotypes for each marker using both the
number of NMIs among imputed SNPs and the
estimated r̂2 values generated by MACH. A total
of 4,225 markers failed only the r̂2 criteria, 1,145
failed only the NMI criteria, and 103 markers
failed both. While the number of NMIs and the
imputation r̂2 were negatively correlated (coeffi-
cient )0.41), removing imputed SNPs by the
number of observed NMIs provided an additional
filter for identifying poorly imputed markers.
We tested the imputed genotypes of 15,552 SNPs
for association with BP in a two-step procedure.
First, we tested each marker using MQLS (25), a
fast test that corrects for relatedness among indi-
viduals. However, MQLS loses power by not fully
modeling the pedigree structure. Hence, we fol-
lowed up each promising signal (p < 0.1) using
LAMP (23). Our results showed 11 SNPs with
p-values < 10)4, with the most significant being
rs4339604 (p = 9.4 · 10)6, MAF = 0.057, physi-
cal position = 128.93 Mb), followed by rs7824868
(p = 2.1 · 10)5, MAF = 0.11, physical posi-
tion = 128.59 Mb) (Fig. 2). Note that the most
significant result near 128 Mb is located in a gene
desert.
Discussion
We analyzed a sample of 3,512 individuals in 737
families and tested 2,756 genotyped SNPs span-
ning 16 Mb across the previously identified
linkage peak in the 8q24 region (9). Furthermore,
we imputed and tested all common HapMap
SNPs in this region. Among the genotyped
markers, the most significantly associated SNPs
are located close to 133 Mb near KCNQ3, which
is consistent with the linkage peak identified by
genome-wide linkage analysis (9). Our results
provided further suggestive evidence that genetic
variants in ST3GAL1 or ADCY8 may be associ-
ated with BP (15, 16). Compared to our previous
results (16), we identified the same candidate
genes with somewhat more significant association
p-values; all variants identified by Zandi et al.
were also nominally significant (p < 0.05) in our
analysis. However, appropriately evaluating these
p-values is challenging. Adjusting the most sig-
nificant result for the number of sequenced
markers results in a Bonferroni-corrected
p = 0.13 (uncorrected p = 4.8 · 10)5). However,
Bonferroni correction assumes independent tests,
and the SNPs in this region are highly correlated.
Moreover, permutation analysis cannot be
applied to assess significance because of the
family structure in our dataset. Hence, it is
difficult to assess experiment-wide statistical sig-
nificance of our results. Including imputed SNPs
added additional signals with suggestive evidence
for association, although no SNPs were signifi-
cant after stringent (Bonferroni) correction for
multiple testing.
All genes implicated by our analysis have
previously been implicated as candidates for BP
and ⁄or other psychiatric disorders. KCNQ3 has
been shown to be expressed highly specifically to
brain and coexpressed with KCNQ2 in most brain
regions (26). KCNQ2 has been implicated to be
associated with BP through the phosphatidyl-
inositol phosphate pathway (27), and both
KCNQ2 and KCNQ3 are key components to
form a voltage-gated potassium channel that is
important in the regulation of neuronal excitabil-
ity (26). Although no peer-reviewed evidence has
been forthcoming on KCNQ3 as a susceptibility
gene for BP disorder, a recently published U.S.
patent proposed using a single nucleotide muta-
tion in KCNQ3 gene to assess the presence or
predisposition to schizophrenia, BP, or a related
mental disorder in a subject (28). Furthermore,
our findings have an intriguing connection
to replicated GWAS results. ANK3 anchors
voltage-gated sodium channels, and both ANK3
Table 1. Top 10 results of single-marker association tests for genotyped markers using LAMP under a multiplicative model with a disease prevalence of 1%
Marker Position (Mb) MAF Gene Location p-value
rs2673582 133.59 0.425 KCNQ3 27 Kb upstream 4.80E-05
rs4871780 128.36 0.421 1.20E-04
rs3750889 132.07 0.406 ADCY8 Intron 5.00E-04
rs1023096 132.10 0.419 ADCY8 Intron 7.00E-04
rs6986303 134.55 0.289 ST3GAL1 Intron 1.10E-03
rs6984550 133.63 0.200 KCNQ3 64 Kb upstream 1.20E-03
rs10095649 135.23 0.133 0.0026
rs4523235 132.31 0.303 0.0027
rs10094837 135.27 0.138 0.0028
rs17602731 133.59 0.314 KCNQ3 32 Kb upstream 0.0032
MAF = minor allele frequency.
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and subunits of the calcium channel are down-
regulated in response to lithium treatment in mice
(29). Hence, the results from both ANK3 and
KCNQ3 are consistent with the involvement of an
ion channelopathy in BP (30), which was also
supported by a recent pathway-based analysis on
GWAS data in BP (31).
The product of ADCY8 catalyzes the formation
of cyclic AMP from ATP, where cyclic AMP may
be involved in BP pathogenesis as a target for
lithium and other mood stabilizing agents (32, 33).
De Mooij-van Malsen et al. (34) showed that
ADCY8 was differentially expressed in specific
brain regions as a function of avoidance behav-
ior in mice. The authors further explored the
human homologous 8q24 region using a candidate
gene approach to test association with BP with
genotypes from a GWAS and reported nominally
significant associations with ADCY8 (p = 0.0055)
and KCNQ3 (p = 0.0029). The product of the
ST3GAL1 gene is a type II membrane protein that
catalyzes the transfer of sialic acid from CMP-sialic
acid to galactose-containing substrates. A recent
family-based association of candidate genes
reported evidence of association of ST3GAL1 to
BP (empirical p-value < 0.005) (35).
As none of the signals we observed can suffi-
ciently explain the linkage signal in 8q24, it is likely
that additional BP variants exist in this region.
However, as testing 15,552 additional imputed
SNPs did not generate additional interesting
signals, our panel of 2,756 SNPs likely captured
most of the common haplotype variation in the
8q24 region. Therefore, typing additional common
variants in this region would not result in new
findings. Our results clearly show that the common
variants in the 8q24 region do not explain the
previously observed linkage peak (9). This may be
for one of two reasons: (i) the linkage peak may be
a false positive, and the replications of the linkage
peak are the result of publication bias; or (ii) the
causal genetic variants in this region may be
individually rare SNPs or copy number variants,
which association tests of common SNP markers
have low power to detect. To assess the contribu-
tion of rare variants in 8q24, it will be necessary to
sequence a set of candidate genes or the entire 8q24
region in a sample of BP cases. Our results indicate
at least two potential starting points.
In summary, we identified three biologically
feasible signals for association with BP, but more
research is required to understand the contribution
of genes in the 8q24 region to BP.
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